紧急医疗 药剂师 处方机构 解决门诊处方问题的处方权
Kevin Burnham1,2, Christina Tran2, Leandra Garcia2
1The University of Texas at Tyler School of Medicine, Tyler, Texas, USA.
Journal of the American College of Emergency Physicians open
|November 13, 2025
概括
具有协作实践协议 (CPA) 的急诊药剂师 (EMP) 可以独立解决出院处方问题,改善患者护理,并可能减少急诊室 (ED) 的重新访问. 这种由药剂师领导的模式增强了护理连续性,并优化了提供者的时间.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
- 紧急医疗 紧急医疗
背景情况:
- 出院处方问题是护理连续性的常见障碍.
- 紧急医疗药剂师 (EMP) 能够很好地解决这些问题.
- 合作实践协议 (CPA) 可以扩大药剂师的实践范围.
研究的目的:
- 评估CPA授予EMP规范权力的实施和影响.
- 评估EMP在解决门诊出院处方问题的有效性.
- 确定对患者再访和护理连续性的影响.
主要方法:
- 根据CPA,EMP根据CPA发布的处方的回顾性图表审查.
- 收集有关患者人口统计,处方问题和干预措施的数据.
- 分析患者在3个月和6个月后再次访问急诊室 (ED).
主要成果:
- EMP解决了295个免费处方问题,主要与保险/负担能力和药物不可用性有关.
- 在59.7%的干预中,处方了其他治疗方法;止痛药是最常见的.
- 观察到低的ED复诊率 (11.2%在3个月,13.2%在6个月),没有重大安全问题.
结论:
- 通过CPA的广泛的EMP规范权力改善了护理连续性,并可能减少ED重访.
- 这种模式优化了药剂师的利用,并可作为其他机构的框架.
- 药剂师驱动的护理过渡提高了患者的治疗结果和医疗保健系统的效率.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Dosage Regimens: Designs and Approaches
248
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
248
Healthcare Agencies II
1.0K
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
1.0K
Drug Control Governance: Regulatory Bodies and Their Impact
473
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
473
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


